Pfizer Anticipates A 'Bolus Of Revenue' From RSV, Prevnar 20 Launches This Year

 
• By Jessica Merrill
  
vaccine
Pfizer expects new vaccines to deliver a boost to revenues • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business